New A2A adenosine receptor antagonists: a structure-based upside-down interaction in the receptor cavity

Bioorg Chem. 2019 Nov:92:103183. doi: 10.1016/j.bioorg.2019.103183. Epub 2019 Aug 5.

Abstract

Adenosine receptor antagonists are generally based on heterocyclic core structures presenting substituents of various volumes and chemical-physical profiles. Adenine and purine-based adenosine receptor antagonists have been reported in literature. In this work we combined various substituents in the 2, 6, and 8-positions of 9-ethylpurine to depict a structure-affinity relationship analysis at the human adenosine receptors. Compounds were rationally designed trough molecular modeling analysis and then synthesized and evaluated at radioligand binding studies at human adenosine receptors. The new compounds showed affinity for the human adenosine receptors, with some derivatives endowed with low nanomolar Ki data, in particular at the A2AAR subtype. The purine core proves to be a versatile core structure for the development of novel adenosine receptor antagonists with nanomolar affinity for these membrane proteins.

Keywords: Adenosine receptor antagonists; Adenosine receptor ligands; Adenosine receptors; Medicinal chemistry, molecular modeling; Purinergic receptors; Radioligand binding studies; Rational design.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine A2 Receptor Antagonists / chemical synthesis*
  • Adenosine A2 Receptor Antagonists / metabolism*
  • Amino Acid Sequence
  • Animals
  • Binding Sites
  • CHO Cells
  • Cricetulus
  • Humans
  • Ligands
  • Male
  • Models, Molecular
  • Molecular Structure
  • Protein Binding
  • Purines / chemical synthesis*
  • Purines / metabolism*
  • Radioligand Assay
  • Rats, Wistar
  • Receptor, Adenosine A2A / metabolism*
  • Structure-Activity Relationship

Substances

  • Adenosine A2 Receptor Antagonists
  • Ligands
  • Purines
  • Receptor, Adenosine A2A